Philip J. Aliotta MD

Philip J. Aliotta
MD

Contact Information
Western New York Urology Associates
3085 Harlem Road, Suite 200
Cheektowaga, NY 14225
Phone: 716-844-5000
aliotta@buffalo.edu



Education and Training:

  • Residency, Urology Residency PGY 3-5, State University of New York at Buffalo (1987)
  • Residency, Surgical Residency PGY1-2, MIllard Fillmore Hospitals (1984)
  • MD, M.D., Autonomous, University of Guadalajara School of Medicine, (1981)
  • BA, Biology, Sociology & Anthropology, Canisius College (1976)

Employment:

  • Chief of Urology, Catholic Health Systems (2018-present)
  • Medical Executive Committee, Sisters Hospital Representative of the Catholic Health (2016-present)
  • Board Member, Executive Committee, Sisters of Charity Hospital, Buffalo, New York (2014-present)
  • Executive Committee, Western New York Urology Associates, LLC (2014-present)
  • President, 8th District Branch, Medical Society of the State of New York (2013-present)
  • Chair, Department of Urology, Sisters of Charity Hospital (2009-present)
  • Chair, Department of Urology, St. Joseph Campus, Sister’s of Charity Hospital (2009-present)
  • Association of Clinical Research Professionals (1998-present)



Professional Memberships:

  • American Society of Reproductive Medicine
  • American Urological Association
  • Buffalo Urologic Society
  • Endourology Society
  • Erie County Medical Society
  • New York State Urologic Society
  • New York State Medical Society
  • Northeast Section American Urological Association
  • Society for Study of Male Reproduction (SSMR)
  • Society for Study of Male Reproduction and Urology (SMRU)
  • Society for Study of Impotence
See all (1 more)

Presentations:

  • "Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." International Neurotoxin Association Meeting (TOXINS) (2017)
  • "The Efficacy and Safety of Onabotulinumtoxin A and Solifenacin Compared to Placebo in Solifenacin-Naïve Patients with Idiopathic Overactive Bladder: Results from a Multicentre, Randomised, Double-Blind Trial" British Association of Urological (2016)
  • "Positive Outcomes After the First Treatment with Onabotulinumtoxin A Persist Long-term With Repeat Treatments in Patients With Neurogenic Detrusor Overactivity." Society of Urodynamics, Female Pelvic Medicine & Urogentical Reconstruction (2016)
  • "Long Term Sustained Safety and Efficacy if Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." Italian Society of Urodynamics, (2015)
  • "Perirectal Hydrogel Spacer Application in Men Receiving Prostate Radiotherapy: A Prospective Multicenter Randomized Controlled Trial." American Urological Association (2015)
  • "Positive Response to First Onabotulinumtoxin A Treatment Persists Long-term with Repeat Treatments in Patients with Neurogenic Detrusor Overactivity" Congress of the European association of Urology (2015)
  • ". Long Term, Sustained Safety and Efficacy of Repeat Onabotulinumtoxin A Treatment in Multiple Sclerosis Patients with Neurogenic Detrusor Overactivity." American Committee for Treatment and Research in MS/European Committee for Treatment and Research (2014)

Service Activities:

  • Chief of Urology (2018–present)
  • Sisters Hospital Representative of the Catholic Health Medical Executive Committee (2016–present)
  • Department of Urology; Chair (2009–present)
  • Consortium for Multiple Sclerosis Centers Chair Bladder/Pelvic Floor; Chair (2008–present)
  • Catholic Health System of WNY; Board Member (2007–present)
  • Niagara Health Care Quality Council (2005–present)
  • Office Professional Medical Conduct, Department of Health New York State Urologic Reviewer; Reporter (2002–present)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Western New York Urology Associates
3085 Harlem Road, Suite 200
Cheektowaga, NY 14225
Phone: 716-844-5000
aliotta@buffalo.edu